Displaying 1521 - 1540 of 4735
Monier Lifetile LLC, Boral Ltd., and Lafarge S.A, In the Matter of
The FTC charged that Boral Ltd. and LaFarge SA violated antitrust laws by establishing a joint venture, Monier Lifetile LLC, that combined their concrete roofing tile (CRT) manufacturing divisions. Boral and LaFarge are the two largest producers of CRT in the United States. To settle FTC charges that the joint venture would likely substantially reduce competition in the market for CRT, Monier Lifetile LLC agreed to sell production facilities in Arizona, California and Florida to CRH PLC.
1901003 Informal Interpretation
1901002 Informal Interpretation
1901001 Informal Interpretation
Statement of Chairman Simons, Commissioner Phillips, and Commissioner Wilson In the Matter of Sycamore Partners II, L.P., Staples, Inc. and Essendant Inc.
Statement of Commissioner Chopra In the Matter of Sycamore Partners II, L.P., Staples, Inc. and Essendant Inc.
Statement of Commissioner Slaughter In the Matter of Sycamore Partners II, L.P., Staples, Inc. and Essendant Inc.
Statement of Commissioner Wilson In the Matter of Sycamore Partners II, L.P., Staples, Inc. and Essendant Inc.
FTC Imposes Conditions on Staples’ Acquisition of Office Supply Wholesaler Essendant Inc.
Sycamore Partners II, L.P., Staples, Inc. and Essendant Inc., In the Matter of
Office supply distributors Staples Inc. and Essendant Inc. have agreed to a settlement as part of the companies’ proposed $482.7 million merger in order to resolve Federal Trade Commission allegations that the deal may have harmed competition in the market for office supply products sold to small- and mid-sized businesses.
FTC Requests Public Comment on an Application from Praxair and Linde to Approve Sale of an Industrial Gases Plant to LyondellBasell
FTC Requests Public Comment on an Application from Praxair and Linde to Approve Sale of Industrial Gases Assets to Matheson Tri-Gas, Inc.
FTC Imposes Conditions in Joint Venture among Three Producers of PET Resin
FTC Announces the Tenth Session of its Hearings on Competition and Consumer Protection in the 21st Century
FTC Requests Public Comment on an Application from Praxair and Linde to Approve Sale of Industrial Gases Assets to a Messer Group GmbH/CVC Capital Partners Joint Venture
FTC Hearing #10: Competition and Consumer Protection Issues in U.S. Broadband Markets
FTC Approves Teva Petition to Reopen and Modify Decision and Order in Case Involving Watson Pharmaceuticals Inc.’s Acquisition of Actavis Inc.
Watson Pharmaceuticals / Actavis Inc., In the Matter of
The FTC required Watson Pharmaceuticals, Inc. and Actavis Inc. to sell the rights and assets to 18 drugs to Sandoz International GmbH and Par Pharmaceuticals, Inc, and relinquish the manufacturing and marketing rights to three others, to settle charges that Watson’s proposed $5.9 billion acquisition of Actavis would otherwise be anticompetitive. The settlement protects competition in the markets for 21 current and future generic drugs, used to treat a wide range of conditions ranging from hypertension and diabetes to anxiety and attention deficit hyperactivity disorder (ADHD).
There is a related federal proceeding and two related administrative proceedings:
Displaying 1521 - 1540 of 4735